Pictet Asset Management
BCRX icon

Pictet Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Pictet Asset Management’s Portfolio BCRX Stock Details BCRX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$9.03M Buy
2025
Q2 		$9.06M Buy
2025
Q1 		$4.8M Buy
2024
Q4 		$199K Buy
2024
Q3 		$149K Hold
2024
Q2 		$121K Hold
2024
Q1 		$99.6K Hold
2023
Q4 		$117K Sell
2023
Q3 		$29.7M Buy